Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other Non-Current Liabilities (2020)

Tango Therapeutics (TNGX) has 1 years of Other Non-Current Liabilities data on record, last reported at $5000.0 in Q4 2020.

  • For Q4 2020, Other Non-Current Liabilities changed N/A year-over-year to $5000.0; the TTM value through Dec 2020 reached $5000.0, changed N/A, while the annual FY2020 figure was $5000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $5000.0 in Q4 2020 per TNGX's latest filing.
  • Across five years, Other Non-Current Liabilities topped out at $5000.0 in Q4 2020 and bottomed at $5000.0 in Q4 2020.